<DOC>
	<DOC>NCT01122355</DOC>
	<brief_summary>The purpose of the study is to compare the efficacy and tolerability of fenofibrate 160 mg and niacin 1500 mg in patients with hypertriglyceridemia and low HDL-cholesterol. The primary end point is the percent change of apoB/A1 and the secondary end points are other lipid parameters and biomarkers.</brief_summary>
	<brief_title>Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<criteria>Triglyceride 150500 mg/dL and HDLcholesterol &lt; 45 mg/dL after 8 week dietary run in period 2079 years old Lowdensity lipoprotein (LDL)cholesterol â‰¥ 130 mg/dL without any lipidmodifying drug History of cerebrovascular or cardiovascular diseases Creatinine &gt; 2.0 mg/dL Transaminase &gt; 2x upper limit of normal Gall bladder disease Cancer Pregnant or breast feeding women History of adverse events associated with test drugs</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>